Mode d'administration Levetiracetam SUN solution à diluer doit être utilisée par voie intraveineuse uniquement et la dose recommandée doit être diluée dans au
levetiracetam sun epar product information fr
KEPPRA (lévétiracétam) Antiépileptique Présentation Flacon 500 mg/5 mL Reconstitution / Dilution / Administration Informations techniques
KEPPRA
KEPPRA can be initiated with either intravenous or oral administration Partial Onset Seizures In clinical trials of oral KEPPRA daily doses of 1000 mg 2000
s lbl
1 jui 2019 · Perfusion IV : dilution dans 100 ou 250 KEPPRA® Dispensation hospitalière Temp ambiante 500 mg / 5 mL solution inj
modalite dadministration des injectables
Dilution de 1 à 2 amp dans un flex de nutrition parentérale Dilution standard perfusion IV continue : Equivalent Keppra®
adulte admin medic inj
Perfusion IV : dilution uniquement avec NaCl 0 9 (conc min 0 2 mg/mL) KEPPRA (levetiracetam) Amp 500 mg / 5 mL (concentré pour perfusion)
ped admin medic inj
En utilisant le présent Guide d'administration intraveineuse des Dose de charge : 60 mg/kg (20 - 70 mg/kg) I V en 15 minutes (maximum: 4500 mg)
levetiracetam keppra
7 oct 2019 · ®KEPPRA est une marque déposée des entreprises du groupe UCB été réalisées en utilisant l'administration i v Les études à dose unique
Keppra pm fr oct
KEPPRA injection is for intravenous use only and must be diluted prior to administration KEPPRA injection (500 mg/5 mL) should be diluted in 100 mL of a compatible diluent [see Dosage and Administration (2 7)] and administered intravenously as a 15-minute IV infusion Product with particulate matter or discoloration should not be used
s s lbl
KEPPRA injection is for intravenous use only and must be diluted prior to administration KEPPRA injection (500 mg/5 mL) should be diluted in 100 mL of a compatible diluent [see Dosage and Administration (2 7)] and administered intravenously as a 15-minute IV infusion Product with particulate matter or discoloration should not be used
s lbl
KEPPRA injection should be administered as a 15-minute IV infusion One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL) KEPPRA injection may be mixed with the following diluents and antiepileptic drugs and may be stored in polyvinyl chloride (PVC) bags
s lbl
of KEPPRA injection should be equivalent to those of oral KEPPRA At the end of the intravenous treatment period the patient may be switched to KEPPRA (levetiracetam) injection for intravenous use KEPPRA oral administration at the equivalent daily dosage and frequency Initial U S Approval: 1999 (2 4 2 5)
s lbl
KEPPRA is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy KEPPRA injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible 2 DOSAGE AND ADMINISTRATION
s lbl